Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates

被引：174

作者：

Shukla, R ^{[1
]}

Thomas, TP ^{[1
]}

Peters, J ^{[1
]}

Kotlyar, A ^{[1
]}

Myc, A ^{[1
]}

Baker, JR ^{[1
]}

机构：

[1] Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Dept Internal Med, Div Allergy, Ann Arbor, MI 48109 USA

来源：

CHEMICAL COMMUNICATIONS | 2005年 / 46期

关键词：

D O I：

10.1039/b507350b

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

PAMAM dendrimer-RGD-4C peptide conjugate was synthesized and in vitro targeting efficacy to integrin receptor expressing cells was studied by flow cytometry and confocal microscopy.

引用

页码：5739 / 5741

页数：3

共 16 条

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].

Arap, W ;

Pasqualini, R ;

Ruoslahti, E .

SCIENCE, 1998, 279 (5349) :377-380

[2] Solution structures and integrin binding activities of an RGD peptide with two isomers [J].

Assa-Munt, N ;

Jia, X ;

Laakkonen, P ;

Ruoslahti, E .

BIOCHEMISTRY, 2001, 40 (08) :2373-2378

[3] TUMOR VASCULATURE - A POTENTIAL THERAPEUTIC TARGET [J].

BAILLIE, CT ;

WINSLET, MC ;

BRADLEY, NJ .

BRITISH JOURNAL OF CANCER, 1995, 72 (02) :257-267

[4] Dendrimers in drug research [J].

Boas, U ;

Heegaard, PMH .

CHEMICAL SOCIETY REVIEWS, 2004, 33 (01) :43-63

[5] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].

BROOKS, PC ;

CLARK, RAF ;

CHERESH, DA .

SCIENCE, 1994, 264 (5158) :569-571

[6]

Chen XY, 2004, J NUCL MED, V45, P1776

[7] Endothelial signaling during development [J].

Cleaver, O ;

Melton, DA .

NATURE MEDICINE, 2003, 9 (06) :661-668

[8]

de Groot FMH, 2002, MOL CANCER THER, V1, P901

[9] Integrin targeting using RGD-PEI conjugates for in vitro gene transfer [J].

Kunath, K ;

Merdan, T ;

Hegener, O ;

Häberlein, H ;

Kissel, T .

JOURNAL OF GENE MEDICINE, 2003, 5 (07) :588-599

[10] The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer [J].

Los, M ;

Voest, EE .

SEMINARS IN ONCOLOGY, 2001, 28 (01) :93-105

← 1 2 →